GL1X · GenesisL1 explorer

Research workbench

Diversity in the type II natural killer T cell receptor repertoire and antigen specificity leads to differing CD1D docking strategies

Analyse Diversity in the type II natural killer T cell receptor repertoire and antigen… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6MSS
Type
protein
Length
790 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
A11B8.2 nkt TCR alpha-chain; A11B8.2 nkt TCR beta-chain; Antigen-presenting glycoprotein…
UniProt
P11609, P01887
Ligands
SRV, NAG
Pockets
10 · best druggability 0.87

Structure

x-ray diffraction · 4 distinct chains · 12% helix, 47% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AA11B8.2 nkt TCR alpha-chainprotein1812% helix, 49% strand—
BA11B8.2 nkt TCR beta-chainprotein2418% helix, 49% strand—
CAntigen-presenting glycoprotein CD1D1protein27027% helix, 42% strandP11609
DBeta-2-microglobulinprotein980% helix, 52% strandP01887

Ligands and binding sites

  • SRV · (2S)-2-(heptadecanoyloxy)-3-{[(10S)-10-methyloctadecanoyl]oxy}propyl alpha-D-glucopyranosiduronic acid · ligand · chains A, C
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17700.870.8976SRV
27430.710.7868empty
3540.690.9719empty
42860.630.8039empty
51890.510.7732empty

Interfaces

4 interfaces between chains.

  • A–B · 2135 Ų buried · 29 hydrogen bonds · protein-protein
  • C–D · 1202 Ų buried · 13 hydrogen bonds · protein-protein
  • A–C · 535 Ų buried · 5 hydrogen bonds · protein-protein
  • B–C · 471 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 disulfide, 3 glycan (disulfide, N-glycosylation).

Compared structures

  • 6MSS · Diversity in the type II Natural Killer T cell receptor repertoire and antigen… · the same entry in another collection · chain A against A, TM-score 1.00
  • P11609 · AlphaFold monomer V2.0 prediction for antigen-presenting glycoprotein CD1D1 (P11609) · a predicted model of the same protein · chain C against A, TM-score 0.99
  • P01887 · AlphaFold monomer V2.0 prediction for beta-2-microglobulin (P01887) · a predicted model of the same protein · chain D against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.